Alternative Data for Progyny
About Progyny
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States.
| Price | $26.71 |
| Target Price | Sign up |
| Volume | 1,550,000 |
| Market Cap | $2.24B |
| Year Range | $18.01 - $26.82 |
| Dividend Yield | 0% |
| PE Ratio | 40.64 |
| Analyst Rating | 36% buy |
| Industry | Health Care Services |
In the news
 |
Progyny (PGNY): Reassessing Valuation After a Strong Year and Recent Pullback in the Share PriceDecember 6 - Yahoo |
 |
Progyny: Growth Has Returned (Rating Upgrade)November 18 - SeekingAlpha |
|
Progyny (PGNY): Gauging Valuation After Recent Share Price MomentumNovember 17 - Yahoo |
|
PGNY vs. HQY: Which Stock Is the Better Value Option?November 14 - Yahoo |
 |
Progyny, Inc. 2025 Q3 - Results - Earnings Call PresentationNovember 11 - SeekingAlpha |
|
Why Progyny (PGNY) Is Up 19.6% After Raising Earnings Guidance and Announcing a $200M BuybackNovember 8 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '25 | 313M | 241M | 73M | 14M | 25M | 0.450 |
| Q2 '25 | 333M | 254M | 79M | 17M | 28M | 0.480 |
| Q1 '25 | 324M | 248M | 76M | 15M | 25M | 0.480 |
| Q4 '24 | 298M | 235M | 63M | 11M | 17M | 0.420 |
| Q3 '24 | 287M | 227M | 59M | 10M | 13M | 0.400 |
Insider Transactions View All
| Swartz Allison filed to sell 72,719 shares at $24.6. December 8 '25 |
| Livingston Mark S. filed to sell 47,921 shares at $25.5. December 4 '25 |
| Swartz Allison filed to sell 73,657 shares at $26.9. December 2 '25 |
| Livingston Mark S. filed to sell 48,358 shares at $25.5. November 19 '25 |
| Anevski Peter filed to buy 680,251 shares at $24.3. November 17 '25 |
Similar companies
Read more about Progyny (PGNY) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, app downloads, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, x mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Progyny?
The Market Cap of Progyny is $2.24B.
What is Progyny's PE Ratio?
As of today, Progyny's PE (Price to Earnings) ratio is 40.64.
What is the current stock price of Progyny?
Currently, the price of one share of Progyny stock is $26.71.
How can I analyze the PGNY stock price chart for investment decisions?
The PGNY stock price chart above provides a comprehensive visual representation of Progyny's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Progyny shares. Our platform offers an up-to-date PGNY stock price chart, along with technical data analysis and alternative data insights.
Does PGNY offer dividends to its shareholders?
As of our latest update, Progyny (PGNY) does not offer dividends to its shareholders. Investors interested in Progyny should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Progyny?
Some of the similar stocks of Progyny are Abbott Laboratories, HCA Healthcare, Cardinal Health, Henry Schein, and Idexx Laboratories.
.
